Lee Jae-myung Administration Faces Criticism for Priorizing Healthcare Industry Growth Over Public Access
A coalition of advocacy groups is sharply criticizing the Lee Jae-myung administration’s frist budget plan, alleging a meaningful shift in priorities away from bolstering national health insurance and towards fostering growth within the healthcare industry. The budget, currently under consideration in the National Assembly, is being viewed as a crucial indicator of the administration’s long-term direction.
The Lee Jae-myung government entered office emphasizing “growth,” a traditionally pro-business term suggesting policies designed to increase corporate profits. This emphasis, critics argue, is now clearly reflected in the healthcare budget, with resources disproportionately allocated to industry expansion rather than equitable access to care.
One key concern centers around the administration’s commitment to expanding government support for national health insurance. Promises made during the “State administration 5-year plan” remain largely unfulfilled,according to a statement released by the Movement Headquarters to Stop Medical Privatization and Realize free Medical Care. National treasury support for health insurance is only increasing by a marginal 1.5 percent, rising from ₩6,211 billion to ₩7,820 billion – a figure that fails to keep pace with inflation and falls far short of the legally mandated 20 percent support rate.
“National treasury support is not a favor given by the state, but an obligation,” a senior official within the advocacy coalition stated. In early March, the Lee Jae-myung government announced a government support percentage 0.2 percent lower than that of the previous Yoon Seok-yeol administration (14.4 percent versus 14.2 percent), drawing significant backlash.
This perceived underfunding of public health insurance is contrasted sharply with significant increases in funding for the biohealth industry, which has seen a 3.5-fold increase in budgetary support. This disparity, critics say, reveals the administration’s true priorities.
Furthermore, the budget continues to pursue reforms to the fixed-rate medical benefit system initially championed by the Yoon Seok-yeol government – a system that critics argue shifted costs onto the poorest citizens. While the Lee Jae-myung administration has not abolished the reform, it has reportedly cut the budget allocated to support for low-income individuals, reducing medical expense support for the lowest class and decreasing disaster medical expense support by 28.5 percent. Support for essential public healthcare in medically vulnerable areas has also been reduced by 0.7 percent, despite stated commitments to expansion.
This budgetary approach, according to the coalition, prioritizes advancements in areas like artificial intelligence (AI) and the biohealth pharmaceutical industry at the expense of basic healthcare access for ordinary citizens. “With this budget, you can’t go to the emergency room,” a representative from the Health World Network explained. “Medical gaps such as pediatric open learning cannot be resolved at all.”
The administration’s focus on growth within the healthcare industry is also raising concerns about the long-term sustainability of health insurance finances. The rapid introduction of commercial telemedicine platforms and innovative medical equipment,often through a “pre-entry post-evaluation” process,is seen as a potential drain on health insurance funds,leading to increased medical costs and rising premiums.
Critics argue that the Lee Jae-myung government’s strategy represents a betrayal of its commitment to address the country’s serious medical gaps. Thay are calling for a significant increase in investment in public healthcare, permanent legislation guaranteeing national treasury support, and a re-evaluation of the budget to prioritize the needs of the population over industry growth.
The coalition, comprised of over 40 organizations including nurses associations, pharmaceutical societies, labor unions, and patient advocacy groups, is urging the administration to reconsider its approach and prioritize equitable access to healthcare for all citizens.
